Nanostics Revenue and Competitors

Edmonton, AB ca

Location

$17M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nanostics's total funding is $17M.

Employee Data

  • Nanostics has 22 Employees.(i)
  • Nanostics grew their employee count by 38% last year.

Nanostics's People

NameTitleEmail/Phone
1
Co-Founder & COOReveal Email/Phone
2
Founder, Board Chair and CEOReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Chief Commercialization OfficerReveal Email/Phone
5
Chief Technology OfficerReveal Email/Phone
6
VP Sales and MarketingReveal Email/Phone
7
VP Clinical EngagementReveal Email/Phone
8
Clinical Laboratory Manager and Senior ScientistReveal Email/Phone
9
Jr QA/RA ManagerReveal Email/Phone
10
Clinical ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M913%N/AN/A
#2
$3.6M467%$1.7MN/A
#3
$2.5M3214%N/AN/A
#4
$3.4M44-4%N/AN/A
#5
$11.8M7641%N/AN/A
#6
$3.6M2426%N/AN/A
#7
$1.2M10-9%N/AN/A
#8
$4.5M20-17%N/AN/A
#9
N/A46-8%$100KN/A
#10
$3.1M1755%$13.4MN/A
Add Company

What Is Nanostics?

Nanostics Inc. is a private Canadian company that develops and commercializes novel and noninvasive diagnostic tests. Its core technology, ClarityDX®, uses advanced machine learning algorithms to create a disease risk score that predicts the presence of diseases. ClarityDX is applicable to a wide range of cancers and other diseases. Nanostics’ lead product, ClarityDX Prostate®, is a test that improves the accuracy of detecting clinically significant prostate cancer. Go to https://www.nanosticsdx.com/clarity-dx-prostate/ to order ClarityDX Prostate today.

keywords:N/A

$17M

Total Funding

22

Number of Employees

N/A

Revenue (est)

38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.5M2222%N/A
#2
N/A2257%$16M
#3
$3.5M23-21%N/A
#4
$2.3M23N/AN/A
#5
$6.2M2310%N/A